Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 18032501000001114 | Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 18032601000001113 | Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Is a | Octreotide 30mg powder and solvent for injection suspension vial | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has active ingredient | Somatostatin | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has active ingredient | Octreotide | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has active ingredient | Octreotide acetate | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has active ingredient | Synthetic hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has manufactured dose form | Powder for conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Is a | Sandostatin LAR | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Octreotide | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has specific active ingredient | Octreotide acetate | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has dispensed dose form | Powder and solvent for suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Has basis of strength substance | Octreotide | true | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Is a | Octreotide 30mg powder and solvent for suspension for injection vials | false | Inferred relationship | Existential restriction modifier | ||
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Is a | Octreotide 30mg powder and solvent for suspension for injection vials | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial | Is pack of | False | Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Inferred relationship | Existential restriction modifier | |
| Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial | Has AMP | True | Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR